Literature DB >> 21714000

Functional magnetic resonance imaging exploration of combined hand and speech movements in Parkinson's disease.

Serge Pinto1, Laura Mancini, Marjan Jahanshahi, John S Thornton, Elina Tripoliti, Tarek A Yousry, Patricia Limousin.   

Abstract

Among the repertoire of motor functions, although hand movement and speech production tasks have been investigated widely by functional neuroimaging, paradigms combining both movements have been studied less so. Such paradigms are of particular interest in Parkinson's disease, in which patients have specific difficulties performing two movements simultaneously. In 9 unmedicated patients with Parkinson's disease and 15 healthy control subjects, externally cued tasks (i.e., hand movement, speech production, and combined hand movement and speech production) were performed twice in a random order and functional magnetic resonance imaging detected cerebral activations, compared to the rest. F-statistics tested within-group (significant activations at P values < 0.05, familywise error corrected), between-group, and between-task comparisons (regional activations significant at P values < 0.001, uncorrected, with cluster size > 10 voxels). For control subjects, the combined task activations comprised the sum of those obtained during hand movement and speech production performed separately, reflecting the neural correlates of performing movements sharing similar programming modalities. In patients with Parkinson's disease, only activations underlying hand movement were observed during the combined task. We interpreted this phenomenon as patients' potential inability to recruit facilitatory activations while performing two movements simultaneously. This lost capacity could be related to a functional prioritization of one movement (i.e., hand movement), in comparison with the other (i.e., speech production). Our observation could also reflect the inability of patients with Parkinson's disease to intrinsically engage the motor coordination necessary to perform a combined task.
Copyright © 2011 Movement Disorder Society.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21714000      PMCID: PMC3184369          DOI: 10.1002/mds.23799

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  29 in total

1.  Cortical motor reorganization in akinetic patients with Parkinson's disease: a functional MRI study.

Authors:  U Sabatini; K Boulanouar; N Fabre; F Martin; C Carel; C Colonnese; L Bozzao; I Berry; J L Montastruc; F Chollet; O Rascol
Journal:  Brain       Date:  2000-02       Impact factor: 13.501

Review 2.  Pathophysiology of the basal ganglia in Parkinson's disease.

Authors:  J A Obeso; M C Rodríguez-Oroz; M Rodríguez; J L Lanciego; J Artieda; N Gonzalo; C W Olanow
Journal:  Trends Neurosci       Date:  2000-10       Impact factor: 13.837

3.  Anatomy and physiology of the basal ganglia: implications for deep brain stimulation for Parkinson's disease.

Authors:  Brian H Kopell; Ali R Rezai; Jin Woo Chang; Jerrold L Vitek
Journal:  Mov Disord       Date:  2006-06       Impact factor: 10.338

Review 4.  Functional architecture of basal ganglia circuits: neural substrates of parallel processing.

Authors:  G E Alexander; M D Crutcher
Journal:  Trends Neurosci       Date:  1990-07       Impact factor: 13.837

5.  Attention to action in Parkinson's disease: impaired effective connectivity among frontal cortical regions.

Authors:  James Rowe; Klaas Enno Stephan; Karl Friston; Richard Frackowiak; Andrew Lees; Richard Passingham
Journal:  Brain       Date:  2002-02       Impact factor: 13.501

Review 6.  The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease.

Authors:  W R Gibb; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-06       Impact factor: 10.154

7.  Speech perception deficits in Parkinson's disease: underestimation of time intervals compromises identification of durational phonetic contrasts.

Authors:  Susanne Gräber; Ingo Hertrich; Irene Daum; Sybille Spieker; Hermann Ackermann
Journal:  Brain Lang       Date:  2002-07       Impact factor: 2.381

8.  Hypophonia in Parkinson's disease: neural correlates of voice treatment revealed by PET.

Authors:  M Liotti; L O Ramig; D Vogel; P New; C I Cook; R J Ingham; J C Ingham; P T Fox
Journal:  Neurology       Date:  2003-02-11       Impact factor: 9.910

9.  Subthalamic nucleus stimulation and dysarthria in Parkinson's disease: a PET study.

Authors:  Serge Pinto; Stéphane Thobois; Nicolas Costes; Didier Le Bars; Alim-Louis Benabid; Emmanuel Broussolle; Pierre Pollak; Michèle Gentil
Journal:  Brain       Date:  2004-01-21       Impact factor: 13.501

10.  The functional anatomy of parkinsonian bradykinesia.

Authors:  Robert S Turner; Scott T Grafton; Anthony R McIntosh; Mahlon R DeLong; John M Hoffman
Journal:  Neuroimage       Date:  2003-05       Impact factor: 6.556

View more
  15 in total

1.  Functional neuroimaging of motor control in Parkinson's disease: a meta-analysis.

Authors:  Damian M Herz; Simon B Eickhoff; Annemette Løkkegaard; Hartwig R Siebner
Journal:  Hum Brain Mapp       Date:  2013-10-05       Impact factor: 5.038

Review 2.  Speech disorders in Parkinson's disease: early diagnostics and effects of medication and brain stimulation.

Authors:  L Brabenec; J Mekyska; Z Galaz; Irena Rektorova
Journal:  J Neural Transm (Vienna)       Date:  2017-01-18       Impact factor: 3.575

3.  Comparative analysis of speech impairment and upper limb motor dysfunction in Parkinson's disease.

Authors:  Jan Rusz; Tereza Tykalová; Radim Krupička; Kateřina Zárubová; Michal Novotný; Robert Jech; Zoltán Szabó; Evžen Růžička
Journal:  J Neural Transm (Vienna)       Date:  2016-12-08       Impact factor: 3.575

4.  The effects of a simulated fMRI environment on voice intensity in individuals with Parkinson's disease hypophonia and older healthy adults.

Authors:  Jordan L Manes; Ellen Herschel; Katharine Aveni; Kris Tjaden; Todd Parrish; Tanya Simuni; Daniel M Corcos; Angela C Roberts
Journal:  J Commun Disord       Date:  2021-08-31       Impact factor: 2.288

5.  Effects of dopaminergic replacement therapy on motor speech disorders in Parkinson's disease: longitudinal follow-up study on previously untreated patients.

Authors:  Jan Rusz; Tereza Tykalová; Jiří Klempíř; Roman Čmejla; Evžen Růžička
Journal:  J Neural Transm (Vienna)       Date:  2016-02-03       Impact factor: 3.575

6.  Brain Motor Network Changes in Parkinson's Disease: Evidence from Meta-Analytic Modeling.

Authors:  Damian M Herz; David Meder; Julia A Camilleri; Simon B Eickhoff; Hartwig R Siebner
Journal:  Mov Disord       Date:  2021-01-11       Impact factor: 10.338

7.  Levodopa effects on hand and speech movements in patients with Parkinson's disease: a FMRI study.

Authors:  Audrey Maillet; Alexandre Krainik; Bettina Debû; Irène Troprès; Christelle Lagrange; Stéphane Thobois; Pierre Pollak; Serge Pinto
Journal:  PLoS One       Date:  2012-10-09       Impact factor: 3.240

8.  Motor matters: tackling heterogeneity of Parkinson's disease in functional MRI studies.

Authors:  Štefan Holiga; Karsten Mueller; Harald E Möller; Tomáš Sieger; Matthias L Schroeter; Josef Vymazal; Evžen Růžička; Robert Jech
Journal:  PLoS One       Date:  2013-02-13       Impact factor: 3.240

9.  The subthalamic microlesion story in Parkinson's disease: electrode insertion-related motor improvement with relative cortico-subcortical hypoactivation in fMRI.

Authors:  Robert Jech; Karsten Mueller; Dušan Urgošík; Tomáš Sieger; Štefan Holiga; Filip Růžička; Petr Dušek; Petra Havránková; Josef Vymazal; Evžen Růžička
Journal:  PLoS One       Date:  2012-11-07       Impact factor: 3.240

10.  The intrinsic resting state voice network in Parkinson's disease.

Authors:  Anneliese B New; Donald A Robin; Amy L Parkinson; Claudia R Eickhoff; Kathrin Reetz; Felix Hoffstaedter; Christian Mathys; Martin Sudmeyer; Christian Grefkes; Charles R Larson; Loraine O Ramig; Peter T Fox; Simon B Eickhoff
Journal:  Hum Brain Mapp       Date:  2015-01-27       Impact factor: 5.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.